HLA-C and viral infectious disease: In addition to the protective effects of HLA-C and activating KIR interactions during pregnancy complications [discussed in section HLA-C Recognition by Decidual NK Cells (dNK)], individuals who carry activating KIR also have a significantly improved outcome during viral infections including HCMV, HIV, HCV, and HPV infections (117–121).